Genomic Unity® Motor Neuron Disorders Analysis

NR005

Motor neuron disorders affect the nerves that control the body’s voluntary muscles. They are characterized by progressive muscle weakness and atrophy, spasticity and overactive tendon reflexes.

Genomic Unity® Motor Neuron Disorders Analysis is an effective test for the genetic cause of muscle weakness in patients with clinical symptoms consistent with the following inherited motor neuron disorders:

As well as related disorders.

Order this test when the patient presents with clinical symptoms consistent with motor neuron disorders like amyotrophic lateral sclerosis, hereditary spastic paraplegia or spinal muscular atrophy and you'd like the option to reflex up to Genomic Unity® Whole Genome Analysis.

  • Sequencing analysis of motor neuron disorder associated genes
  • Del/dup analysis of motor neuron disorder associated genes
  • Frontotemporal dementia and Amyotrophic lateral sclerosis (FTD-ALS) STR analysis: C9ORF72
  • Spinal and bulbar muscular atrophy STR analysis: AR

Optionally includes:

  • Reflex to Genomic Unity® Whole Genome Analysis or Genomic Unity® Exome Analysis

ALDH18A1, ALS2, AMPD2, ANG, AP4B1, AP4E1, AP4M1, AP4S1, AP5Z1, AR, ARL6IP1, ASAH1, ATL1, ATP13A2, ATP7A, B4GALNT1, BICD2, BSCL2, C12ORF65, C19ORF12, C9ORF72, CAPN1, CCT5, CHCHD10, CHMP2B, CPT1C, CYP2U1, CYP7B1, DCTN1, DDHD1, DDHD2, DNAJB2, DYNC1H1, ENTPD1, ERBB4, ERLIN1, ERLIN2, EXOSC3, EXOSC8, FA2H, FARS2, FBXO38, FIG4, FUS, GARS1, GBA2, GJC2, GRN, HACE1, HINT1, HNRNPA1, HSPB1, HSPB3, HSPD1, IBA57, IGHMBP2, KDM5C, KIDINS220, KIF1A, KIF1C, KIF5A, L1CAM, LAS1L, MAG, MAPT, MARS1, MATR3, NEFH, NIPA1, NT5C2, OPTN, PFN1, PLEKHG5, PLP1, PNPLA6, PRPH, RAB3GAP2, REEP1, REEP2, RTN2, SACS, SETX, SIGMAR1, SLC16A2, SLC1A4, SLC33A1, SLC52A3, SLC5A7, SMN1, SMN2, SOD1, SPART, SPAST, SPG11, SPG21, SPG7, SQSTM1, TAF15, TARDBP, TBK1, TECPR2, TFG, TRPV4, TUBA4A, UBA1, UBAP1, UBQLN2, USP8, VAMP1, VAPB, VCP, VPS37A, VRK1, WASHC5, ZFYVE26, ZFYVE27

 

SNVs and Indels up to 50bp
99.7% sensitivity
99.7% positive predictive value

Note that the SMN2 gene is only analyzed for determination of copy number for assessment of severity of spinal muscular atrophy (SMA).

Structural variants:
96% clinical sensitivity

Short tandem repeats:
Due to the variable nature of repetitive sequence and sequence specific differences in detection, repeat evaluation and orthogonal confirmation is performed on a case-by-case basis. Reportable pathogenic or intermediate repeat expansions may be reported with or without repeat count.

  • 81443, 81173, 81329, 81336, 81403 x2, 81404 x3, 81405 x2, 81406 x2, 81407, 81479 x3

The CPT codes provided are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Blood - 5ml
Saliva - contact us for a kit
gDNA - 5μg

Please contact customer service for turnaround time.

Please do not submit Protected Health Information (PHI) through this email address.

If you need to submit Protected Health Information (PHI), please call us at 617-209-2090 and we will work with you to submit the information through an alternate mechanism.

Otherwise, please continue: